• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

Podcast: Why Are CPG Brands Freaking Out About Ozempic?

by Michael Wolf
November 17, 2023November 17, 2023Filed under:
  • News
  • Podcasts
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email this to a friend (Opens in new window)

On this week’s Spoon Podcast, SuperGut CEO Marc Washington joins me to talk about why new GLP-1 drugs like Ozempic and Wegovy keep CPG brand CEOs up at night.

These new drugs, which got their start as a new class of pharmaceuticals that help control type 2 diabetes, have become very popular in recent years as weight loss miracle drug. They are hugely effective in suppressing appetites and reducing the overall calorie intake of those taking them, so much so that some speculate that they could have a significant impact on the overall demand for food if, as predicted, tens of millions begin to take them in coming years as prices come down and they become available in more accessible formats. 

Marc’s company, SuperGut, creates a natural alternative to GLP-1 drugs in the form of supplements, snacks and bars. His journey to become CEO of SuperGut was born out of a personal loss and a chance meeting with Dave Friedberg, the CEO of The Production Board. 

You can listen to our conversation by clicking below, downloading to your device, or heading over to Apple Podcasts, Spotify or wherever you listen to podcasts.


Related

Get the Spoon in your inbox

Just enter your email and we’ll take care of the rest:

Find us on some of these other platforms:

  • Apple Podcasts
  • Spotify
Tagged:
  • Ozempic
  • Podcast
  • SuperGut

Post navigation

Previous Post Amazon’s Roving Robot Gets a Job. Will Restaurants & Retail Bite?
Next Post Google Announces Winners of the Single-Use Plastics Challenge

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Get The Spoon in Your Inbox

The Spoon Podcast Network!

Feed your mind! Subscribe to one of our podcasts!

Food Waste Gadgets Can’t Get VC Love, But Kickstarter Backers Are All In
Report: Restaurant Tech Funding Drops to $1.3B in 2024, But AI & Automation Provide Glimmer of Hope
Don’t Forget to Tip Your Robot: Survey Shows Diners Not Quite Ready for AI to Replace Humans
A Week in Rome: Conclaves, Coffee, and Reflections on the Ethics of AI in Our Food System
How ReShape is Using AI to Accelerate Biotech Research

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.